Will Ashworth

Will Ashworth

InvestorPlace Contributor

Expertise: Public and private companies, Portfolio construction

About Will:
Will Ashworth has written about investments full-time since 2008. He loves investing and is passionate about helping others put their money to work. He particularly enjoys creating model portfolios that stand the test of time.

Publications where he’s appeared include InvestorPlace, The Motley Fool Canada, Investopedia, Kiplinger, and several others in both the U.S. and Canada. He lives in Halifax, Nova Scotia.

You can follow Will on LinkedIn. 

Recent Articles

Clover Health Investments Will Likely Give Up More Ground Before It Approaches $10

By Will Ashworth, InvestorPlace Contributor

Clover Health continues to trade below its $10 IPO price. I’ve got 35,000 reasons not to buy CLOV stock at current prices.

When It Comes to Ocugen Stock, I’m Damned If I Do or Don’t 

By Will Ashworth, InvestorPlace Contributor

After sprinting to $16.20 in early May, Ocugen’s fallen back to earth. What does it have to do to get OCGN stock back into double digits?

There Just Might Be a Better Buy Than Nio Stock

By Will Ashworth, InvestorPlace Contributor

Through May of 2021, Nio’s delivered 33,873 electric vehicles. That’s 225% higher than 2020. Does that make Nio stock a best buy? 

What Happens to SoFi Technologies Now That It’s Public?

By Will Ashworth, InvestorPlace Contributor

Chamath Palihapitiya’s SPAC completed its merger with SoFi Technologies on May 28. SOFI stock began trading June 1. Is there hope for it?

10 Billionaires Who Got Even Wealthier During the Pandemic

By Will Ashworth, InvestorPlace Contributor

A ton of billionaires got richer during the pandemic. The stats are overwhelming. These 10 people made the wealth gap even greater.

I Would Hope Inovio Isn’t Attracting ANY Serious Money

By Will Ashworth, InvestorPlace Contributor

A recent article wondered if the smart money preferred Ocugen or Inovio. I would hope neither INO stock or OCGN is getting any serious money.

Riot Blockchain Has All Of Its Eggs In A Volatile Bitcoin Basket

By Will Ashworth, InvestorPlace Contributor

Riot Blockchain closed its acquisition of Whinstone US and analysts expect that will drive RIOT stock higher. There's just one problem.

Why Mark Cuban Is Right About Ethereum

By Will Ashworth, InvestorPlace Contributor

Mark Cuban looks to smart contracts and their utility when assessing blockchain such as Ethereum. I couldn’t agree more. Here’s why. 

Crypto Promoter Sees Dogecoin Going to $1 Trillion, But Is It Plausible?

By Will Ashworth, InvestorPlace Contributor

Wall Street millionaire and Dogecoin believer, Jenny Ta, recently argued it could get to a trillion dollar market cap. Is she right?

Sundial Growers or Indiva: Which is the Better Buy?

By Will Ashworth, InvestorPlace Contributor

Sundial Growers owns 18.45% of Indiva, who manufacture Wana Brand edibles in Canada. Is SNDL stock a buy or is Indiva a better call?

Load More